With the threat of infections that can’t be cured with antibiotics larger than previously thought, new antibiotics are needed. But few companies are working to develop them. Antibiotics are expensive to develop and because their use is limited, there’s not a lot of profit potential for pharmaceutical companies, CBS News consumer investigative correspondent Anna Werner reports.
Still, the need is great, as drug-resistant infections kill more than 35,000 people a year, or about one person every 15 minutes, according to the Centers for Disease Control and Prevention.
>>CLICK HERE to Read the Full Article on WCBI.com
